Skip to content

Thoraflex™ Hybrid THP3038X100ARecalls & reported problems

Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant

All models of Thoraflex Hybrid (33)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
1
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881026756), received between May 8, 2024 and Mar 4, 2025 — classified as 1 death, 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Insufficient Device Problem Information2

Patient problems

  • Aneurysm1
  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • DeathMar 4, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    DOCTOR WAS UNABLE TO CONTROL BLEEDING AT THE PROXIMAL END OF THE AORTA DUE TO CONTINUOUS FILLING OF THE FALSE LUMEN. AS AN ATTEMPT TO REGAIN CONTROL, AT RELAY PRO WAS DEPLOYED TO ELIMINATE THE DISTAL PREFUSION OF THE FALSE LUMEN. THE RELAY PRO WAS SUCCESSFULLY DEPLOYED AND SUCCESSFULLY COVERED THE FENESTRATIONS WITHIN ITS LENGTH. ADDITIONAL FENESTRATIONS WERE NOTED DISTAL TO THE RELAY GRAFT THAT WERE STILL FILLING THE FALSE LUMEN. IT IS BELIEVED THAT THIS LED TO THE BLEEDING THAT COULD NO LONGER BE CONTROLLED PROXIMALLY. PATIENT OUTCOME: THE PATIENT DID NOT SURVIVE THE SURGERY. AFTER SPEAKING WITH DOCTOR, THEY WERE NOT LEFT WITH THE IMPRESSION THAT THE DEVICE DID NOT HAVE A ROLE IN THE OUTCOME. IT WAS MENTIONED THAT HE SIMPLY WAS UNABLE TO CONTROL/STOP THE BLEEDING. THIS REPORT IS BEING SUBMITTED AS FOLLOW UP #1 FOR MANUFACTURING REPORT NUMBER 9612515-2025-00019 TO PROVIDE EVENT CLOSURE INFORMATION FOR (B)(4).

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 21512465 ↗
  • InjuryMay 8, 2024Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    AUTOMATED E-MAIL NOTIFICATION RECEIVED FROM STUDY DATABASE ON 10 APR 2024 REPORTING THE EVENT OF DESCENDING AORTIC ANEURYSM FROM 02 APR 24. FURTHER INFORMATION RELATED TO THIS COMPLAINT WAS PRESENTED ON 25 APR 24 WHICH DESCRIBED THAT SURGICAL FINDINGS INCLUDE A D-SINE (DISTAL STENT GRAFT-INDUCED NEW ENTRY) AT THE END OF THE STENT GRAFT. IMPLANTATION OF THE DEVICE WAS ON 19 OCT 23. PATIENT OUTCOME: PATIENT HAS HAD A THORACOTOMY WITH RESECTION AND GRAFT REPLACEMENT OF DESCENDING THORACIC ANEURYSM. A SECONDARY INTERVENTION WAS PERFORMED ON 08 APR 24, WHICH INVOLVED A LEFT POSTEROLATERAL THORACOTOMY FOR RESECTION AND REPLACEMENT OF DESCENDING THORACIC AORTA WITH 32 MM SIENNA GRAFT (PROXIMAL ANASTOMOSIS AT THE DISTAL END OF PREVIOUS THORAFLEX GRAFT, DISTAL ANASTOMOSIS JUST ABOVE THE DIAPHRAGM). THE EVENT AND TREATMENT ARE ONGOING.

    Patient problems: Aneurysm

    MAUDE report 19266442 ↗

Other Hybrid stent graft, thoracic aortic lesion treatment devices

All Hybrid stent graft, thoracic aortic lesion treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page